Impact of Lifestyle and Socioeconomic Position on the Association Between Non-steroidal Anti-inflammatory Drug Use and Major Adverse Cardiovascular Events: A Case-Crossover Study

Kasper Bonnesen (), Lars Pedersen, Vera Ehrenstein, Marie Stjerne Grønkjær, Henrik Toft Sørensen, Jesper Hallas, Timothy Lee Lash and Morten Schmidt
Additional contact information
Kasper Bonnesen: Aarhus University and Aarhus University Hospital
Lars Pedersen: Aarhus University and Aarhus University Hospital
Vera Ehrenstein: Aarhus University and Aarhus University Hospital
Marie Stjerne Grønkjær: Copenhagen University Hospital-Bispebjerg and Frederiksberg
Henrik Toft Sørensen: Aarhus University and Aarhus University Hospital
Jesper Hallas: University of Southern Denmark
Timothy Lee Lash: Emory University
Morten Schmidt: Aarhus University and Aarhus University Hospital

Drug Safety, 2023, vol. 46, issue 6, No 2, 533-543

Abstract: Abstract Introduction It is unknown whether the cardiovascular risks associated with non-steroidal anti-inflammatory drug (NSAID) use differ according to lifestyle and socioeconomic position. Objective We examined the association between NSAID use and major adverse cardiovascular events (MACE) within subgroups defined by lifestyle and socioeconomic position. Methods We conducted a case-crossover study of all adult first-time respondents to the Danish National Health Surveys of 2010, 2013, or 2017, without previous cardiovascular disease, who experienced a MACE from survey completion through 2020. We used a Mantel-Haenszel method to obtain odds ratios (ORs) of the association between NSAID use (ibuprofen, naproxen, or diclofenac) and MACE (myocardial infarction, ischemic stroke, heart failure, or all-cause death). We identified NSAID use and MACE via nationwide Danish health registries. We stratified the analyses by body mass index, smoking status, alcohol consumption, physical activity level, marital status, education, income, and employment. Results Compared with non-use, the OR of MACE was 1.34 (95% confidence interval: 1.23–1.46) for ibuprofen, 1.48 (1.04–2.43) for naproxen, and 2.18 (1.72–2.78) for diclofenac. When comparing NSAID use with non-use or the individual NSAIDs with each other, we observed no notable heterogeneity in the ORs within subgroups of lifestyle and socioeconomic position for any NSAID. Compared with ibuprofen, diclofenac was associated with increased risk of MACE in several subgroups with high cardiovascular risk, e.g., individuals with overweight (OR 1.52, 1.01–2.39) and smokers (OR 1.54, 0.96–2.46). Conclusions The relative increase in cardiovascular risk associated with NSAID use was not modified by lifestyle or socioeconomic position.

Date: 2023
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-023-01298-0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:46:y:2023:i:6:d:10.1007_s40264-023-01298-0

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-023-01298-0

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().